Michael Amatangelo
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
- Hematology 40
- Multiple Myeloma Research and Treatments 38
- Acute Myeloid Leukemia Research 3
- Oncology 21
- Peptidase Inhibition and Analysis 9
- Cancer Cells and Metastasis 5
- Chemokine receptors and signaling 3
- Co-authors
- Edna CukiermanDorothy A. BeachamAnjan ThakurtaJosé R. Conejo-GarcíaDavid W. SpeicherRugang ZhangAzat GaripovAndres J. Klein–Szanto
- Journals
- Blood (25 papers)Cell Reports Medicine (2 papers)Current Protocols in Cell Biology (2 papers)American Journal Of Pathology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Michael Amatangelo
49 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Hematology 679
- Oncology 587
- Molecular Biology 1.3k
- Cancer Research 262
- Immunology and Allergy 86
Countries citing papers authored by Michael Amatangelo
This map shows the geographic impact of Michael Amatangelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Amatangelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Amatangelo more than expected).
Fields of papers citing papers by Michael Amatangelo
This network shows the impact of papers produced by Michael Amatangelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Amatangelo. The network helps show where Michael Amatangelo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Amatangelo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 27 | |
| 9 | 2020 | 7 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 144 | |
| 12 | 2017 | 249 | |
| 13 | 2017 | 1 | |
| 14 | Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers Hit paper breakdown → | 2015 | 492 |
| 15 | 2015 | 154 | |
| 16 | 2013 | 64 | |
| 17 | 2012 | 48 | |
| 18 | 2010 | 54 | |
| 19 | 2009 | 12 | |
| 20 | 2005 | 187 |
About Michael Amatangelo
Michael Amatangelo is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Cancer Research, having authored 50 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (33 papers), Peptidase Inhibition and Analysis (9 papers), Histone Deacetylase Inhibitors Research (9 papers), Ubiquitin and proteasome pathways (7 papers), Cancer Cells and Metastasis (5 papers), Acute Myeloid Leukemia Research (3 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Hematology (679 citations), Oncology (587 citations), Molecular Biology (1.3k citations), Cancer Research (262 citations) and Immunology and Allergy (86 citations). Michael Amatangelo has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Edna Cukierman, Dorothy A. Beacham, Anjan Thakurta, José R. Conejo-García, David W. Speicher, Rugang Zhang, Azat Garipov, Andres J. Klein–Szanto, Daniela Bassi and Benjamin G. Bitler. Their work appears in journals such as Blood, Cell Reports Medicine, Current Protocols in Cell Biology, American Journal Of Pathology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.